JPMorgan Starts Quest Diagnostics (DGX) at Neutral
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $243.45 +0.70%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
JPMorgan initiates coverage on Quest Diagnostics (NYSE: DGX) with a Neutral. PT $64.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.52 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $58.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts UMB Financial (UMBF) at Overweight
- Wells Fargo Starts Progyny (PGNY) at Overweight
- Piper Sandler Starts Sphere Entertainment (SPHR) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
